Is ABT a good stock to buy? We came across a bullish thesis on Abbott Laboratories on Compounding Dividends’s Substack by TJ Terwilliger. In this article, we will summarize the bulls’ thesis on ABT.

Abbott Laboratories stock reached a 52-week low, hitting a price of 105.24 USD, just pennies above its bottom of 105.27 USD. This milestone reflects a challenging period for the h ...

Shares of Abbott Laboratories ABT slipped 1.61% to $105.46 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 1.51% to 6,506.48 ...

The healthcare giant is roughly 22% down from its 52-week high of $139.06 as of writing. However, for investors focused on ...

This company has delivered earnings and dividend growth over time. Abbott’s innovation and a new acquisition could spur more growth in the years to come. 10 stocks we like better than Abbott ...

Abbott Laboratories' (NYSE: ABT) January 2026 price pullback is making its stock look attractively valued. The move, driven more by market angst and fear than by any real weaknesses, seems to be a ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

These two stocks make fantastic long-term holdings.

Abbott (ABT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...